REFERENCES
- Kan YW. Molecular pathology of α-thalassemia. Ann NY Acad Sci. 1985; 445: 28–36
- Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003; 17(1)43–53
- Neishabury M, Oberkanins C, Moheb LA, Pourfathollah AA, Kahrizi K, Keyhany E, et al. High prevalence of the −α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003; 27(1)53–55
- Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H. α-Globin gene deletion and point mutation analysis among Iranian patients with microcytic hypochromic anemia. Haematologica. 2003; 88(10)1196–1197
- Hadavi V, Taromchi AH, Malekpour M, Gholami B, Law H-Y, Almadani N, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007; 92(07)992–993
- Gohari LH, Petrou M, Felekis X, Christopoulos G, Kleanthous M. Identification of α-thalassemia mutations in Iranian individuals with abnormal hematological indices and normal Hb A2. Hemoglobin. 2003; 27(2)129–132
- Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects. Am J Hematol. 2003; 74(2)99–103
- Yavarian M, Karimi M, Zorai A, Harteveld CL, Giordano PC. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005; 29(1)43–50
- Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994; 46(3)208–213
- Baysal E, Kleanthous M, Bozkurt G, Kypri A, Kalogirou E, Angastiniotis M, et al. α-Thalassaemia in the population of Cyprus. Br J Haematol. 1995; 89(3)496–499
- Lacerra G, Angioletti M, De Girolamo R, Sciorio A, Testa R, Schilliró G, et al. Hb Caserta and Hb Bronte: Two novel hemoglobin variants caused by α2-globin gene mutations. Proceedings of the 6th International Conference on Thalassaemias and the Haemoglobinopathies. St. Paul's BayMalta 1997, Abstract 151
- Harkness M, Harkness DR, Kutlar F, Wilson JB, Webber BB, Codrington JF, et al. Hb Sun Prairie or α2130(H13)Ala→Proβ2, a new unstable variant occurring in low quantities. Hemoglobin. 1990; 14(5)479–489
- Plaseska D, Gu LH, Wilson JB, Codrington JF, Huisman THJ, Hb Dash S. Sun Prairie or α2130(H13)Ala→Proβ2; second observation in an Indian adult. Hemoglobin. 1990; 14(5)491–497
- Passarello C, Giambona A, Prossomariti L, Ammirabile M, Pucci P, Renda D, et al. Hb Southern Italy: Coexistence of two missense mutations (the Hb Sun Prairie α2 130 Ala→Pro and Hb Caserta α2 26 Ala→Thr) in a single HBA2 gene. Br J Haematol. 2008; 143(1)138–142
- Harteveld CL, Wijermans PW, van Delft P, Rasp E, Haak HL, Giordano PC. An α-thalassemia phenotype in a Dutch Hindustani, caused by a new point mutation that creates an alternative splice donor site in the first exon of the α2-globin gene. Hemoglobin. 2004; 28: 255–259
- Harteveld CL, Versteegh FGA, Kok PJMJ, Rooijen-Nijdam van, van Delft P, Giordano PC. Hb Bleuland [α108(G15)Thr→Asn, ACC→AAC (α2)]: A new abnormal hemoglobin associated with a mild α-thalassemia phenotype. Hemoglobin. 2006; 30(3)349–354
- Harteveld CL, Heister JG, Giordano PC, Batelaan D, van Delft P, Haak HL, et al. An IVS1–116 (A→G) acceptor splice site mutation in the α2 globin gene causing α+ thalassaemia in two Dutch families. Br J Haematol. 1996; 95(3)461–466
- Law HY, Luo HY, Wang W, Ho JF, Najmabadi H, Ng IS, et al. Determining the cause of patchwork HBA1 and HBA2 genes: Recurrent gene conversion or crossing over fixation events. Haematologica. 2006; 91(3)297–302
- Ayala S, Colomer D, Aymerich M, Pujades A, Vives-Corrons JL. Nondeletion α-thalassemia: First description of αHphα and αNcoα mutation in a Spanish population. Am J Hematol. 1996; 52(3)144–149
- Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004; 329(7475)1134–1137
- Najmabadi H, Ghamari A, Sahebjam F, Kariminejad R, Hadavi V, Khatibi T, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006; 9(2)93–97